AU524000B2 - 4-(benzothiazole or benzoxadiazole)-1,4-dihydro-pyridine derivatives - Google Patents

4-(benzothiazole or benzoxadiazole)-1,4-dihydro-pyridine derivatives

Info

Publication number
AU524000B2
AU524000B2 AU37252/78A AU3725278A AU524000B2 AU 524000 B2 AU524000 B2 AU 524000B2 AU 37252/78 A AU37252/78 A AU 37252/78A AU 3725278 A AU3725278 A AU 3725278A AU 524000 B2 AU524000 B2 AU 524000B2
Authority
AU
Australia
Prior art keywords
benzoxadiazole
benzothiazole
dihydro
pyridine derivatives
pyridine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU37252/78A
Other languages
English (en)
Other versions
AU3725278A (en
Inventor
Neumann Peter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of AU3725278A publication Critical patent/AU3725278A/en
Application granted granted Critical
Publication of AU524000B2 publication Critical patent/AU524000B2/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU37252/78A 1977-06-20 1978-06-19 4-(benzothiazole or benzoxadiazole)-1,4-dihydro-pyridine derivatives Expired AU524000B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH752077 1977-06-20
CHCH777520 1977-06-20
CH286578 1978-03-16
CHCH782865 1978-03-16

Publications (2)

Publication Number Publication Date
AU3725278A AU3725278A (en) 1980-01-03
AU524000B2 true AU524000B2 (en) 1982-08-26

Family

ID=25691589

Family Applications (1)

Application Number Title Priority Date Filing Date
AU37252/78A Expired AU524000B2 (en) 1977-06-20 1978-06-19 4-(benzothiazole or benzoxadiazole)-1,4-dihydro-pyridine derivatives

Country Status (20)

Country Link
EP (1) EP0000150B1 (zh)
JP (1) JPS54103876A (zh)
AT (1) AT376220B (zh)
AU (1) AU524000B2 (zh)
CA (1) CA1105463A (zh)
CY (1) CY1239A (zh)
DE (1) DE2860708D1 (zh)
DK (1) DK149855C (zh)
ES (1) ES470917A1 (zh)
FI (1) FI64938C (zh)
HK (1) HK65184A (zh)
IE (1) IE47212B1 (zh)
IL (1) IL54948A (zh)
IT (1) IT1105364B (zh)
LU (1) LU88342I2 (zh)
MY (1) MY8500041A (zh)
NL (1) NL930126I2 (zh)
NZ (1) NZ187617A (zh)
PT (1) PT68191A (zh)
SG (1) SG20584G (zh)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH639659A5 (de) * 1978-12-18 1983-11-30 Sandoz Ag Neue 1,4-dihydropyridinderivate, deren herstellung und verwendung.
FI793848A (fi) * 1978-12-18 1980-06-19 Sandoz Ag Benzoxadiazoler och benzothiadiazoler deras framstaellning och farmaceutiska kompositioner innehaollande dessa
BE886259A (fr) * 1979-11-23 1981-05-20 Sandoz Sa Nouveaux medicament a base de derives de la 1,4-dihydropyridine, pour le traitement de l'insuffisance cerebrovasculaire ou a action spamolytique
CH655658B (zh) * 1980-09-18 1986-05-15
FI813460L (fi) * 1980-11-10 1982-05-11 Sandoz Ag Nya 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-pyridinderivat deras framstaellningsfoerfarande och dessa innehaollande farmaceutiska kompositioner
EP0080220B1 (en) * 1981-11-17 1986-02-19 FISONS plc Dihydropyridines, methods for their production and their formulation and use as pharmaceuticals
DE3207982A1 (de) * 1982-03-05 1983-09-08 Bayer Ag, 5090 Leverkusen Neue 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihrer verwendung in arzneimitteln
DE3208628A1 (de) * 1982-03-10 1983-09-22 Bayer Ag, 5090 Leverkusen Neue verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
ZA83959B (en) * 1982-03-10 1984-09-26 Sandoz Ltd 1,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them
FR2528431B1 (fr) * 1982-06-15 1986-01-10 Sandoz Sa Nouveaux derives de la 1,4-dihydropyridine, leur preparation et leur utilisation comme medicaments
FR2554109A1 (fr) * 1983-11-01 1985-05-03 Sandoz Sa Nouveaux derives de la 1,4-dihydropyridine, leur preparation et leur utilisation en therapeutique comme medicaments
IE57810B1 (en) * 1984-03-27 1993-04-21 Delagrange Lab 1,4-dihydropyridine derivatives,their preparation and their use
NL194389C (nl) * 1984-06-14 2002-03-04 Novartis Ag Werkwijze voor het bereiden van een vaste dispersie van een farmaceutisch actief middel dat een lage oplosbaarheid in water heeft, in een vaste matrix van een in water oplosbaar polyalkyleenglycol als drager.
GB8428552D0 (en) * 1984-11-12 1984-12-19 Sandoz Ltd Organic compounds
US5260321A (en) * 1984-11-12 1993-11-09 Sandoz Ltd. Use of 1,4-dihydropyridine derivatives and combinations thereof with calcitonins
GB8616047D0 (en) * 1986-07-01 1986-08-06 Sandoz Ltd A 1 4-dihydropyridine derivatives
IL163666A0 (en) 2002-02-22 2005-12-18 New River Pharmaceuticals Inc Active agent delivery systems and methods for protecting and administering active agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1552911A (en) * 1975-07-02 1979-09-19 Fujisawa Pharmaceutical Co 1,4 dihydropyridine derivatives and the preparation thereof

Also Published As

Publication number Publication date
AT376220B (de) 1984-10-25
IE47212B1 (en) 1984-01-25
HK65184A (en) 1984-08-31
IL54948A (en) 1982-01-31
DK262578A (da) 1978-12-21
CY1239A (en) 1984-06-29
FI781867A (fi) 1978-12-21
EP0000150A1 (en) 1979-01-10
IL54948A0 (en) 1978-08-31
IT7849939A0 (it) 1978-06-19
NZ187617A (en) 1980-12-19
DK149855B (da) 1986-10-13
DK149855C (da) 1987-04-21
ATA443178A (de) 1984-03-15
IE781231L (en) 1978-12-20
JPS54103876A (en) 1979-08-15
NL930126I2 (nl) 1995-02-16
EP0000150B1 (en) 1981-05-20
CA1105463A (en) 1981-07-21
AU3725278A (en) 1980-01-03
PT68191A (fr) 1978-07-01
JPS6360755B2 (zh) 1988-11-25
IT1105364B (it) 1985-10-28
NL930126I1 (nl) 1993-11-01
SG20584G (en) 1985-03-08
DE2860708D1 (en) 1981-08-27
LU88342I2 (fr) 1994-05-04
FI64938C (fi) 1984-02-10
FI64938B (fi) 1983-10-31
MY8500041A (en) 1985-12-31
ES470917A1 (es) 1979-10-01

Similar Documents

Publication Publication Date Title
AU524000B2 (en) 4-(benzothiazole or benzoxadiazole)-1,4-dihydro-pyridine derivatives
AU5848480A (en) 2-(pyrimidinyl-amino)-1,3-diaza-2-cycloalkene derivatives
AU3076477A (en) Piperidine or morpholine derivatives
AU4253078A (en) 1, 2-benzothiazine-1, 1-dioxide derivatives
NL7806245A (nl) Carbostyrilderivaten.
NL7803378A (nl) 5-(2-pyrroyl)-1.2-dihydro-3h-pyrrolo1.2-apyrrool-1- carbonzuurderivaten en werkwijzen ter bereiding ervan.
AU6720087A (en) 4-(2-thiazolyl- and 4-(2-thiazolylamino-phenyl)-1,4- dihydropyridine derivatives
AU516179B2 (en) Imadazo(5, 1-1)-1, 2, 4-triazines
NO783642L (no) Imidazolidenderivater.
AU514452B2 (en) 3, 3, 3-triarylalkyl-4-phenylalkl-4-hydroxy piperidine derivatives
AU517661B2 (en) 5-[4-(diarylmethyl)-1-piperazinyl-alkyl]benzinidazole derivatives
AU517830B2 (en) Piperidine derivatives
AU536055B2 (en) Derivatives of 1,4 dihydropyridine substituted by benzoxadiazole or benzthiadiazole
HK96887A (en) 4-(naphthyl-methyl)piperidine derivatives
AU2288077A (en) Preparation of 2-(2, 2-dicyclohexylethyl) piperidine
AU522242B2 (en) 3-(TETRAZOL-5-yl)-1 AZAXANTHONES
AU515506B2 (en) 1, 2, 4-oxadiazole derivatives
PH14805A (en) 4-(9,10-dihydro-4h-benzo(4,5)cyclohepta-(1,2-b)thiophen-4-ylidene)-piperidine derivatives
AU534398B2 (en) 4-(naphthalenyloxy) piperidine derivatives
AU517110B2 (en) Raise drill
HK71383A (en) 2,5-dihydro-1,2-thiazino (5,6-b) indol-3-carboxamide-1,1-dioxide derivatives
AU519175B2 (en) Raise drill
AU7732381A (en) "4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-pyridine derivatives"
PT68627A (en) Process for the preparation of 2-(2-furoyl)-1,4-dimethyl-pyridinium iodide
AU510611B2 (en) 4-(o-halophenyl)-1,2,4-triazole-3-thiols